1Sugimoto T, Gotoh T, Yagyu S, Kuroda H, Iehara T, et al. (2013) A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines. Cancer Lett 331: 115-121.

2Imashuku S, Inui A, Nakamura T, Tanaka J, Miyake S (1973) Catecholamine metabolism in tissue culture cells of neuroblastoma. J Clin Endocrinol Metab 36: 931-936.

3Biedler JL, Helson L, Spengler BA (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33: 2643-2652.

4Thiele C (1999) Neuroblastoma. In Masters JRW, Palsson B eds. Human Cell Culture. Vol. 1, Norwell: Kluwer Academic Publishers 21-53.

5Sugimoto T, Tatsumi E, Kemshead JT, Helson L, et al. (1984) Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies. J Natl Cancer Inst 73: 51-57.

6Sugimoto T, Sawada T, Arakawa S, Matsumura T, Sakamoto I, et al. (1985) Possible differential diagnosis of neuroblastoma from rhabdomyosarcoma and Ewing's sarcoma by using a panel of monoclonal antibodies. Jpn J Cancer Res 76: 301-307.

7Sugimoto T, Sawada T, Matsumura T, Kemshead JT, Horii Y, et al. (1988) Diagnosis of neuroblastoma metastasis in bone marrow with a panel of monoclonal antibodies. Med Pediatr Oncol 16: 190-196.

8Sugimoto T, Sawada T, Matsumura T, Kemshead JT, Ishii T, et al. (1986) Identical expression of cell surface membrane antigens on 2 parents and 18 cloned cell lines derived from 2 different neuroblastoma metastases of the same patient. Cancer Res 46: 4765-4769.

9Matsumura T, Sugimoto T, Sawada T, Tohru Saida, Kemshead JT (1988) Distinctive membrane phenotypes of neuroblastoma cells and fetal neuroblasts by a panel of monoclonal antibodies. Adv Neuroblastoma Res 2: 395-407.

10Matsumura T, Sugimoto T, Sawada T, Amagai T, Negoro S, Kemshead JT (1987) Cell surface membrane antigen present on neuroblastoma cells but not fetal neuroblasts recognized by a monoclonal antibody (KP-NAC8). Cancer Res 47: 2924-2930.

11Anderson DL (1997) Cellular and molecular biology of neural crest cell lineage determination. Trends Genet 13: 276-280.

12Sugimoto T, Sawada T, Matsumura T, Horii Y, et al. (1987) Morphological differentiation of human neuroblastoma cell lines by a new synthetic polyprenoic acid (E5166). Cancer Res 7: 5433-5438.

13Sugimoto T, Sawada T, Matsumura T, Horii Y, et al. (1998) In: Evans AE, ed. Neuronal differentiation of human neuroblastoma cells by a novel synthetic polyprenoic acid. Advances in Neuroblastoma Res. New York: Alan R. Liss 337-351.

14Sugimoto T, Horii Y, Hino T, Kemshead JT, et al. (1989) Differential susceptibility of HLA class II antigens induced by gamma-interferon in human neuroblastoma cell lines. Cancer Res 49: 1824-1828.

15Sugimoto T, Kato T, Sawada T, Horii Y, Kemshead JT, et al. (1988) Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine. Cancer Res 48: 2531-2537.

16Horii Y, Sugimoto T, Sawada T, Imanishi J, et al. (1989) Differential expression of N-myc and c-src proto-oncogenes during neuronal and schwannian differentiation of human neuroblastoma cells. Int J Cancer 43:305-309.

17Sugimoto T, Ueyama H, Hosoi H, Inazawa J, Kato T, et al. (1991) Alpha-smooth-muscle actin and desmin expressions in human neuroblastoma cell lines. Int J Cancer 48: 277-283.

18Matsumura T, Gotoh T, Sawada T, Sugimoto T (1998) A neuroblastoma cell line derived from a case detected through a mass screening system in Japan: A case report including the biologic and phenotypic characteristics of the cell line. Cancer 82: 1416-1417.

19Sugimoto T, Mine H, Horii Y, Takahashi K, et al. (2000) Neuroblastoma cell lines showing smooth muscle cell phenotypes. Diagn Mol Pathol 9: 221-228.

20Schwab M, Alitalo K, Klempnauer KH, Varmus HE, et al. (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305: 245-248.

21Seeger RG, Brodeur GM, Sather H, Dalton A, Siegel SE, et al. (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313: 1111-1116.

22Hino T, Sugimoto T, Matsumura T, Horii Y, Inazawa J, et al. (1989) Diverse responses to retinoid in morphological differentiation, tumorigenesis and N-myc expression in human neuroblastoma sublines. Int J Cancer 44: 286-291.

23Gotoh T, Hosoi H, Iehara T, Kuwahara Y, Osone S, Tsuchiya K, (2005) Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction. J Clin Oncol 23: 5205-5210.

24Yagyu S, Iehara T, Tanaka S, Gotoh T, Misawa-Furihata A, Teramukai S, et al. (2016) Serum-based quantification of MYCN gene amplification in young patients with neuroblastoma: Potential utility as a surrogate biomarker for neuroblastoma. PLoS One 11: e0161039.

25Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, et al. (1993) Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328: 847-854.

26Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM (1994) Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol 14:759-67.

27Sugimoto T, Kuroda H, Horii Y, Moritake H, Tanaka T, et al. (2001) Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells. Jpn J Cancer Res 92: 152-160.

28Horii Y, Kuroda H, Sugimoto T (1998) Frequent detection of TrkA expression in human neuroblastoma cell lines. Acta Paediatrica Jap 40: 644-646.

29Kuroda H, Sugimoto T, Horii Y, Sawada T (2001) Signaling pathway of ciliary neurotrophic factor in human neuroblastoma cell lines. Med Pediatr Oncol 36: 118-121.

30Kuroda H, Sugimoto T, Ueda K, Tsuchida S, et al. (1991) Different drug sensitivity in two neuroblastoma cell lines established from the same patient before and after chemotherapy. Int J Cancer 47: 732-737.

31Moritake H, Horii Y, Kuroda H, Sugimoto T (2001) Analysis of PTEN/MMAC1 alteration in neuroblastoma. Cancer Genet Cytogenet 125: 151-155.

32Osone S, Hosoi H, Kuwahara Y, Matsumoto Y, et al. (2004) Fenretinide induces sustained activation of JNK/p38 MAPK and apoptosis in a reactive oxygen species-dependent manner in neuroblastoma cells. Int J Cancer. 112: 219-224.

33Tamura S, Hosoi H, Kuwahara Y, Kikuchi K, Otabe O, et al. (2007) Induction of apoptosis by an inhibitor of EGFR in neuroblastoma cells. Biochem Biophys Res Commun 358: 226-232.